Seelos Therapeutics Inc (SEEL)

[eicoman]

I really don't know oldcoach about what will happen at the FDA meeting,
but I do think the patents are worth more than a dollar a share, especially to ferring, I think someone higher up at the FDA came down on the decision and they don't want to approve a permeation enhancer that comes off patent in 2020 that everyone could use in any way once a product is approved, I don't think a bridge study will cut it, the path forward in the USA for DDAIP/Vitaros is a whole new formula, room temp, enantiomer version less than 2.5%, and trials, Apricus can't do that, who would and risk a restricted label or a 3rd denial, the patent on the DDAIP enantiomer version goes to 2031, so maybe if more safety studies/trials can prove it, and it's exclusive, we just don't know how the FDA is going to handle this, maybe a newer technology is coming down the pike that doesn't open the skin and the FDA doesn't want DDAIP, so that leaves Ferring, would Ferring buy Apri for the room temp device, rayva, new version of DDAIP, I would think so but what the hell do I know at this point, look how wrong I have been here